免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Coag-Sense Prothrombin (PT) / INR 監測系統用於病人自我測試

K 號:K212779 · 2022-10-05

決定日期2022-10-05
產品代碼GJS
諮詢委員會HE 請提供完整的描述文本,以便我能夠進行翻譯。
決定相當於

器材摘要

Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing is the device name listed in this FDA 510(k) record. The listed applicant is Coagusense, Inc.. It received FDA 510(k) clearance on 2022-10-05 under 510(k) number K212779. The device is classified under product code GJS. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing?

Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing is a medical device that received FDA 510(k) clearance on 2022-10-05. The listed applicant is Coagusense, Inc.. The 510(k) number is K212779.

When did Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing receive FDA 510(k) clearance?

Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing received FDA 510(k) clearance on 2022-10-05, under 510(k) number K212779.

Who is the listed applicant for Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing?

The FDA 510(k) record lists Coagusense, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing?

The FDA product code for Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-Testing is GJS.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Coagusense, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:GJS)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑